Skip to main content
Erschienen in: Clinical Rheumatology 7/2013

01.07.2013 | Case Based Review

ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review

verfasst von: Petar Lenert, Michael Icardi, Laila Dahmoush

Erschienen in: Clinical Rheumatology | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Minocycline is a synthetic tetracycline-derived antibiotic with significant anti-inflammatory properties that may benefit patients with rheumatoid arthritis. Surprisingly, chronic exposure to minocycline can also cause a breach in immunologic tolerance resulting in a variety of autoimmune syndromes such as drug-induced lupus or autoimmune hepatitis. Vasculitis, most commonly resembling cutaneous polyarteritis nodosa, has also been seen in patients taking this drug. Herein, we present a case of biopsy-proven systemic vasculitis presenting as an ANA (+) ANCA (+) polyarteritis nodosa-like syndrome in a male patient who was taking minocycline for his acne for approximately 2 years. Patient initially presented with constitutional symptoms such as profound weight loss and fatigue, along with myalgias, oligoarticular arthritis, and livedo reticularis. About 2 months later, he developed a severe left testicular pain. Biopsy showed vasculitis complicated with the infarction of the left testis. Angiography revealed microaneurysms in the renal and splenic circulation. Stopping the offending drug, along with the short course of prednisone and hydroxychloroquine, resulted in prompt resolution of his symptoms. We additionally present a comprehensive review of biopsy-proven cases of vasculitis associated with chronic minocycline treatment focusing on its pathogenesis and clinical manifestations.
Literatur
2.
Zurück zum Zitat Sturkenboom MC, Meier CR, Jick H, Stricker BH (1999) Minocycline and lupus-like syndrome in acne patients. Arch Intern Med 159:493–497PubMedCrossRef Sturkenboom MC, Meier CR, Jick H, Stricker BH (1999) Minocycline and lupus-like syndrome in acne patients. Arch Intern Med 159:493–497PubMedCrossRef
3.
Zurück zum Zitat Matsuura T, Shimizu Y, Fujimoto H, Miyazaki T, Kano S (1992) Minocycline-related lupus. Lancet 340:1553PubMedCrossRef Matsuura T, Shimizu Y, Fujimoto H, Miyazaki T, Kano S (1992) Minocycline-related lupus. Lancet 340:1553PubMedCrossRef
4.
Zurück zum Zitat Byrne PA, Williams BD, Pritchard MH (1994) Minocycline-related lupus. Br J Rheumatol 33:674–676PubMedCrossRef Byrne PA, Williams BD, Pritchard MH (1994) Minocycline-related lupus. Br J Rheumatol 33:674–676PubMedCrossRef
5.
Zurück zum Zitat Masson C, Chevailler A, Pascaretti C, Legrand E, Brégeon C, Audran M (1996) Minocycline-related lupus. J Rheumatol 23:2160–2161PubMed Masson C, Chevailler A, Pascaretti C, Legrand E, Brégeon C, Audran M (1996) Minocycline-related lupus. J Rheumatol 23:2160–2161PubMed
6.
Zurück zum Zitat Quilty B, McHugh N (1994) Lupus-like syndrome associated with the use of minocycline. Br J Rheumatol 33:1197–1198PubMedCrossRef Quilty B, McHugh N (1994) Lupus-like syndrome associated with the use of minocycline. Br J Rheumatol 33:1197–1198PubMedCrossRef
8.
Zurück zum Zitat Gordon PM, White MI, Herriot R, Martin JC, Reid DM (1995) Minocycline-associated lupus erythematosus. Br J Dermatol 132:120–121PubMedCrossRef Gordon PM, White MI, Herriot R, Martin JC, Reid DM (1995) Minocycline-associated lupus erythematosus. Br J Dermatol 132:120–121PubMedCrossRef
9.
Zurück zum Zitat Inoue CN, Kondo Y, Suwabe N, Igarashi Y, Tada K (1994) Minocycline-related lupus in childhood. Eur J Pediatr 153:540PubMedCrossRef Inoue CN, Kondo Y, Suwabe N, Igarashi Y, Tada K (1994) Minocycline-related lupus in childhood. Eur J Pediatr 153:540PubMedCrossRef
10.
Zurück zum Zitat Gendi NS, Bowman SJ, Mowat AG (1995) Lupus-like syndrome in patients treated for acne. Br J Rheumatol 34:584–585PubMedCrossRef Gendi NS, Bowman SJ, Mowat AG (1995) Lupus-like syndrome in patients treated for acne. Br J Rheumatol 34:584–585PubMedCrossRef
11.
Zurück zum Zitat Elkayam O, Yaron M, Caspi D (1996) Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA. Ann Rheum Dis 55:769–771PubMedCrossRef Elkayam O, Yaron M, Caspi D (1996) Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA. Ann Rheum Dis 55:769–771PubMedCrossRef
12.
Zurück zum Zitat Dunphy J, Oliver M, Rands AL, Lovell CR, McHugh NJ (2000) Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. Br J Dermatol 142:461–467PubMedCrossRef Dunphy J, Oliver M, Rands AL, Lovell CR, McHugh NJ (2000) Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. Br J Dermatol 142:461–467PubMedCrossRef
13.
Zurück zum Zitat Elkayam O, Levartovsky D, Brautbar C, Yaron M, Burke M, Vardinon N, Caspi D (1998) Clinical and immunological study of seven patients with minocycline-induced autoimmune phenomena. Am J Med 105:484–487PubMedCrossRef Elkayam O, Levartovsky D, Brautbar C, Yaron M, Burke M, Vardinon N, Caspi D (1998) Clinical and immunological study of seven patients with minocycline-induced autoimmune phenomena. Am J Med 105:484–487PubMedCrossRef
14.
Zurück zum Zitat Elkayam O, Yaron M, Caspi D (1999) Minocycline-induced autoimmune syndromes: an overview. Semin Arthritis Rheum 28:392–397PubMedCrossRef Elkayam O, Yaron M, Caspi D (1999) Minocycline-induced autoimmune syndromes: an overview. Semin Arthritis Rheum 28:392–397PubMedCrossRef
15.
Zurück zum Zitat El-Hallak M, Giani T, Yeniay BS, Jacobs KE, Kim S, Sundel RP, Dedeoglu F (2008) Chronic minocycline-induced autoimmunity in children. J Pediatr 153:314–319PubMedCrossRef El-Hallak M, Giani T, Yeniay BS, Jacobs KE, Kim S, Sundel RP, Dedeoglu F (2008) Chronic minocycline-induced autoimmunity in children. J Pediatr 153:314–319PubMedCrossRef
16.
Zurück zum Zitat Schaffer JV, Davidson DM, McNiff JM, Bolognia JL (2001) Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol 44:198–206PubMedCrossRef Schaffer JV, Davidson DM, McNiff JM, Bolognia JL (2001) Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol 44:198–206PubMedCrossRef
17.
Zurück zum Zitat Lawson TM, Amos N, Bulgen D, Williams BD (2001) Minocycline-induced lupus: clinical features and response to rechallenge. Rheumatology (Oxford) 40:329–335CrossRef Lawson TM, Amos N, Bulgen D, Williams BD (2001) Minocycline-induced lupus: clinical features and response to rechallenge. Rheumatology (Oxford) 40:329–335CrossRef
19.
Zurück zum Zitat Hoffman BJ (1945) Sensitivity to sulfadiazine resembling acute disseminated lupus erythematosus. Arch Dermatol 51:190–192CrossRef Hoffman BJ (1945) Sensitivity to sulfadiazine resembling acute disseminated lupus erythematosus. Arch Dermatol 51:190–192CrossRef
20.
Zurück zum Zitat Cameron HA, Ramsay LE (1984) The lupus syndrome induced by hydralazine: a common complication with low dose treatment. Br Med J 289:410–412CrossRef Cameron HA, Ramsay LE (1984) The lupus syndrome induced by hydralazine: a common complication with low dose treatment. Br Med J 289:410–412CrossRef
21.
Zurück zum Zitat Yokogawa N, Vivino FB (2009) Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis. Mod Rheumatol 19:338–347PubMedCrossRef Yokogawa N, Vivino FB (2009) Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis. Mod Rheumatol 19:338–347PubMedCrossRef
22.
Zurück zum Zitat Marina VP, Malhotra D, Kaw D (2012) Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation. Int Urol Nephrol 44(6):1907–9PubMedCrossRef Marina VP, Malhotra D, Kaw D (2012) Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation. Int Urol Nephrol 44(6):1907–9PubMedCrossRef
23.
25.
Zurück zum Zitat Shapiro LE, Uetrecht J, Shear NH (2001) Minocycline, perinuclear antineutrophilic cytoplasmic antibody, and pigment: the biochemical basis. J Am Acad Dermatol 45:787–789PubMedCrossRef Shapiro LE, Uetrecht J, Shear NH (2001) Minocycline, perinuclear antineutrophilic cytoplasmic antibody, and pigment: the biochemical basis. J Am Acad Dermatol 45:787–789PubMedCrossRef
26.
Zurück zum Zitat Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, Pascual V (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3:73ra20PubMedCrossRef Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, Pascual V (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3:73ra20PubMedCrossRef
27.
Zurück zum Zitat Gaffney K, Merry P (1996) Antineutrophil cytoplasmic antibody-positive polyarthritis associated with minocycline therapy. Br J Rheumatol 35:1327PubMedCrossRef Gaffney K, Merry P (1996) Antineutrophil cytoplasmic antibody-positive polyarthritis associated with minocycline therapy. Br J Rheumatol 35:1327PubMedCrossRef
28.
Zurück zum Zitat Marzo-Ortega H, Baxter K, Strauss RM, Drysdale S, Griffiths B, Misbah SA, Gough A, Cunliffe WJ, Emery P (2007) Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study. Br J Dermatol 156:1005–1009PubMedCrossRef Marzo-Ortega H, Baxter K, Strauss RM, Drysdale S, Griffiths B, Misbah SA, Gough A, Cunliffe WJ, Emery P (2007) Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study. Br J Dermatol 156:1005–1009PubMedCrossRef
29.
Zurück zum Zitat Schrodt BJ, Callen JP (1999) Polyarteritis nodosa attributable to minocycline treatment for acne vulgaris. Pediatrics 103:503–504PubMedCrossRef Schrodt BJ, Callen JP (1999) Polyarteritis nodosa attributable to minocycline treatment for acne vulgaris. Pediatrics 103:503–504PubMedCrossRef
30.
Zurück zum Zitat Schrodt BJ, Kulp-Shorten CL, Callen JP (1999) Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris. South Med J 92:502–504PubMedCrossRef Schrodt BJ, Kulp-Shorten CL, Callen JP (1999) Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris. South Med J 92:502–504PubMedCrossRef
31.
Zurück zum Zitat Sakai H, Komatsu S, Matsuo S, Iizuka H (2002) Two cases of minocycline-induced vasculitis. Arerugi 51:1153–1158PubMed Sakai H, Komatsu S, Matsuo S, Iizuka H (2002) Two cases of minocycline-induced vasculitis. Arerugi 51:1153–1158PubMed
32.
Zurück zum Zitat Pelletier F, Puzenat E, Blanc D, Faivre B, Humbert P, Aubin F (2003) Minocycline- induced cutaneous polyarteritis nodosa with antineutrophil cytoplasmic antibodies. Eur J Dermatol 13:396–398PubMed Pelletier F, Puzenat E, Blanc D, Faivre B, Humbert P, Aubin F (2003) Minocycline- induced cutaneous polyarteritis nodosa with antineutrophil cytoplasmic antibodies. Eur J Dermatol 13:396–398PubMed
33.
Zurück zum Zitat Culver B, Itkin A, Pischel K (2005) Case report and review of minocycline-induced cutaneous polyarteritis nodosa. Arthritis Rheum 53:468–470PubMedCrossRef Culver B, Itkin A, Pischel K (2005) Case report and review of minocycline-induced cutaneous polyarteritis nodosa. Arthritis Rheum 53:468–470PubMedCrossRef
34.
Zurück zum Zitat Tehrani R, Nash-Goelitz A, Adams E, Dahiya M, Eilers D (2007) Minocycline- induced cutaneous polyarteritis nodosa. J Clin Rheumatol 13:146–149PubMedCrossRef Tehrani R, Nash-Goelitz A, Adams E, Dahiya M, Eilers D (2007) Minocycline- induced cutaneous polyarteritis nodosa. J Clin Rheumatol 13:146–149PubMedCrossRef
35.
Zurück zum Zitat Katada Y, Harada Y, Azuma N, Matsumoto K et al (2006) Minocycline-induced vasculitis fulfilling the criteria of polyarteritis nodosa. Mod Rheumatol 16:256–259PubMedCrossRef Katada Y, Harada Y, Azuma N, Matsumoto K et al (2006) Minocycline-induced vasculitis fulfilling the criteria of polyarteritis nodosa. Mod Rheumatol 16:256–259PubMedCrossRef
36.
Zurück zum Zitat Ogawa N, Kawai H, Yamakawa I, Sanada M, Sugimoto T, Maeda K (2010) Case of minocycline-induced vasculitic neuropathy. Rinsho Shinkeigaku 50:301–305PubMedCrossRef Ogawa N, Kawai H, Yamakawa I, Sanada M, Sugimoto T, Maeda K (2010) Case of minocycline-induced vasculitic neuropathy. Rinsho Shinkeigaku 50:301–305PubMedCrossRef
37.
Zurück zum Zitat Towns K, Szmitko PE, Smith C, Detsky AS, Mourad O (2011) Clinical problem solving. It's not all in your head. N Engl J Med 365:1329–1334PubMedCrossRef Towns K, Szmitko PE, Smith C, Detsky AS, Mourad O (2011) Clinical problem solving. It's not all in your head. N Engl J Med 365:1329–1334PubMedCrossRef
38.
Zurück zum Zitat Abad S, Kambouchner M, Nejjari M, Dhote R (2006) Additional case of minocycline-induced cutaneous polyarteritis nodosa: comment on the article by Culver et al. Arthritis Rheum 55:831PubMedCrossRef Abad S, Kambouchner M, Nejjari M, Dhote R (2006) Additional case of minocycline-induced cutaneous polyarteritis nodosa: comment on the article by Culver et al. Arthritis Rheum 55:831PubMedCrossRef
39.
Zurück zum Zitat Gait RC, Affleck AG, Leach IH, Varma S (2008) Perinuclear antineutrophilic cytoplasmic antibody-positive polyarteritis nodosa secondary to minocycline treatment for acne vulgaris. J Am Acad Dermatol 58(Suppl 1):S123–S124PubMedCrossRef Gait RC, Affleck AG, Leach IH, Varma S (2008) Perinuclear antineutrophilic cytoplasmic antibody-positive polyarteritis nodosa secondary to minocycline treatment for acne vulgaris. J Am Acad Dermatol 58(Suppl 1):S123–S124PubMedCrossRef
40.
Zurück zum Zitat Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF et al (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 64:625–639CrossRef Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF et al (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 64:625–639CrossRef
41.
Zurück zum Zitat BNF 51 (2006) British National Formulary, vol 5.1.3. BMJ Publishing, London, pp 285–287 BNF 51 (2006) British National Formulary, vol 5.1.3. BMJ Publishing, London, pp 285–287
Metadaten
Titel
ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review
verfasst von
Petar Lenert
Michael Icardi
Laila Dahmoush
Publikationsdatum
01.07.2013
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 7/2013
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2245-z

Weitere Artikel der Ausgabe 7/2013

Clinical Rheumatology 7/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.